VACUNAS EN ADULTOS

Vacunas en Adultos Pablo Gaete 2010

Vacunas. Generalidades ,[object Object],[object Object],[object Object],[object Object],[object Object]

Tetano y Difteria. Immunidad ,[object Object],[object Object],[object Object]

Reporte Pertussis por Grupo de edad, 1990-2008

Tetano and Difteria Vacunas para Adultos ,[object Object],[object Object],[object Object],[object Object],[object Object]

Vacunas Tdap ,[object Object],[object Object],[object Object],[object Object]

Principios Generales para el Uso de Tdap y Td ,[object Object],[object Object]

Personas no Vacunadas ,[object Object],[object Object],[object Object],[object Object],[object Object],*off-label recommendation. See MMWR 2006;55(RR-17)

Tdap y Embarazo ,[object Object],[object Object],[object Object],[object Object],MMWR 2008;57(RR-4)

Tdap y Personal de Salud ,[object Object],[object Object],MMWR 2006;55(RR-17)

Tdap. Contraindicaciones ,[object Object],[object Object]

Tdap/Td. Reacciones Adversas ,[object Object],[object Object],[object Object],[object Object],[object Object],66% - 75% 23% - 24% 21% 3% - 5% 30% - 40%

Impacto de la Influenza ,[object Object],[object Object],MMWR 2009;58 (RR-8)

Virus Influenza ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],A/Fujian/411/2002 (H3N2) Neuraminidase Hemagglutinin Type of nuclear material Virus type Geographic origin Strain number Year of isolation Virus subtype

Vacunas Influenza ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],MMWR 2009;58(RR-8)

Vacunas Influenza ,[object Object],[object Object],[object Object],[object Object],MMWR 2009;58(RR-8)

Vacuna Influenza Inactivada (TIV). Eficacia ,[object Object],[object Object],[object Object],MMWR 2009;58(RR-8)

Vacuna Influenza ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],MMWR 2010;59

TIV ,[object Object],[object Object],[object Object],[object Object],[object Object],MMWR 2006;55(RR-3)

LAIV. Reacciones adversas ,[object Object],[object Object],MMWR 2006;55(RR-3)

Pneumococo ,[object Object],[object Object],[object Object],http://www.cdc.gov/abcs/reports-findings/surv-reports.html

Vacuna neumococica polisacarida ,[object Object],[object Object],[object Object],MMWR 1997;46(RR-8)

[object Object],[object Object],[object Object],Vacuna neumococica polisacarida MMWR 1997;46(RR-8)

Recomendaciones ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],MMWR 1997;46(RR-8)

Candidatos a Revacunacion ,[object Object],[object Object],[object Object],[object Object],[object Object],MMWR 1997;46(RR-8)

Reacciones adversas ,[object Object],[object Object],[object Object],MMWR 1997;46(RR-8)

Herpes Zoster (shingles) ,[object Object],[object Object],[object Object],[object Object],[object Object]

Vacuna Herpes Zoster (Zostavax) ,[object Object],[object Object],[object Object]

Zostavax Clinical Trial ,[object Object],[object Object],[object Object],[object Object],[object Object],NEJM 2005;352(22):2271-84.

ACIP Recomendaciones ,[object Object],[object Object],MMWR 2008;57(RR-5)

Contraindicaciones ,[object Object],[object Object],[object Object],[object Object],MMWR 2008;57(RR-5)

Human Papillomavirus ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Natural History of HPV Infection Within 1 Year 1-5 Years Up to Decades Initial HPV Infection Persistent Infection CIN 2/3 Cervical Cancer CIN 1 Cleared HPV Infection

HPV- Condiciones asociadas ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Vacunas. HPV ,[object Object],[object Object],[object Object],[object Object]

Vacunas. HPV ,[object Object],[object Object],[object Object],[object Object],[object Object]

Esquema ,[object Object],[object Object],[object Object],[object Object]

Correct and consistent condom use may have a protective effect on HPV acquisition, reduce the risk for HPV-associated diseases, and mitigate the adverse consequences of infection with HPV. This statement is required by section 317 of the Public Health Service Act, 42 U.S.C., 243

HPV. Reacciones adversas ,[object Object],[object Object],[object Object],[object Object]

[object Object],Booster NO recomendado rutinariamente. En cualquier grupo de paciente MMWR 2006;55(RR-16)

Candidatos ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],MMWR 2006;55(RR-16)

Reacciones adversas ,[object Object],[object Object],[object Object],[object Object],MMWR 2006;55(RR-16)

Hepatitis A Vaccines ,[object Object],[object Object],[object Object],[object Object]

Twinrix ,[object Object],[object Object],[object Object],[object Object]

Hepatitis A ,[object Object],[object Object],[object Object],[object Object],[object Object],MMWR 2006;55(RR-7)

Hepatitis A Postexposure Prophylaxis ,[object Object],[object Object],[object Object],[object Object],MMWR 2007;56(41):1080-4

Reacciones adversas ,[object Object],[object Object],[object Object],MMWR 2006;55(RR-7)

Measles-Mumps-Rubella (MMR) ,[object Object],[object Object],[object Object],[object Object]

MMR Adverse Reactions ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Varicella Vaccine ,[object Object],[object Object],[object Object],[object Object],[object Object]

Adverse Reactions ,[object Object],[object Object],[object Object],[object Object]

Meningococcal Polysaccharide Vaccine (MPSV) - Menomune ,[object Object],[object Object],[object Object]

MPSV Recommendations ,[object Object],[object Object]

Meningococcal Conjugate Vaccine (MCV) ,[object Object],[object Object],[object Object],[object Object]

Recomendaciones ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],MMWR 2005;54(RR-7)

Reacciones adversas ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],MPSV MCV MMWR 2005;54(RR-7)

Una de las razones para que el adulto no se vacune como debiera, es que su medico no se lo recomiende.

VACUNAS EN ADULTOS

Empfohlen

Empfohlen

Weitere ähnliche Inhalte

Was ist angesagt?

Was ist angesagt? (20)

Andere mochten auch

Andere mochten auch (20)

Ähnlich wie VACUNAS EN ADULTOS

Ähnlich wie VACUNAS EN ADULTOS (20)

Mehr von HOSPITAL CLINICO UNIVERSIDAD DE CHILE

Mehr von HOSPITAL CLINICO UNIVERSIDAD DE CHILE (20)

VACUNAS EN ADULTOS